2023

Long-term real-world effectiveness of Mepolizumab in EGPA: support for a step-up dosing strategy

Laura Castellanos López lauraangelcas@hotmail.com¹, Carlos Melero Moreno², Maria Celeste Marcos^2,3, Ana Isabel Arcos³, Adrian Peláez Laderas³, Carolina Cisneros Serrano^2,3

Online First

Letter to the Editor

doi: 10.23822/EurAnnACI.1764-1489.435

Show more: Authors information and Publication history

Authors Information

¹Pneumolgy Service, Hospital Universitario de Getafe, Madrid, Spain
²Princesa Institute of Health Research, Hospital Universitario de La Princesa, Madrid, Spain
³Pneumolgy Service, Hospital universitario de La Princesa, Madrid, Spain

History

Published: 20 May 2026
Accepted: 29 April 2026
Received: 29 January 2026

KEY WORDS

Eosinophilic granulomatosis with polyangiitis (EGPA); mepolizumab; dose-escalation; real-world evidence; asthma.

Full text PDF

Table of Content: Online First

Letter to the Editor

Severe CSU with low total IgE levels: is the response to omalizumab always delayed or absent?

Riccardo Asero

doi: 10.23822/EurAnnACI.1764-1489.360

Download PDF

Letter to the Editor

Selective Immunoglobulin M Deficiency: an underestimated immunodeficiency

Inês Filipa da Costa Farinha ines_farinha9@hotmail.com¹, António Celso Dias Pereira^2,3, Frederico Eugénio de Castro Soares Regateiro^1,2,4, Ana Maria Pego Todo-Bom Ferreira da Costa^1,2, Emília Maria Antunes Gomes de Faria¹

doi: 10.23822/EurAnnACI.1764-1489.340

Download PDF

Letter to the Editor

Challenges in egg allergy: a retrospective look at the utility of cut-off values

Pedro Botelho Alves^1,*, Helena Pires Pereira helenapereira089@gmail.com^1,*, Isabel Carrapatoso¹, Graça Loureiro¹, Inês Farinha¹, Mariana Lucena¹, Tomás Freitas¹, Ana Todo Bom^1,2

doi: 10.23822/EurAnnACI.1764-1489.336

Download PDF

Original Article

Quantity increase and functional affinity/avidity decrease of anti-FcεRI and anti-IgE autoantibodies in chronic spontaneous urticaria

Lukas Jörg lukas.joerg@insel.ch¹, Nicole Müller-Wirth², Kevin Kammermann², Odile Stalder³, Werner Pichle², Oliver Hausmann^2,4

doi: 10.23822/EurAnnACI.1764-1489.320

Download PDF

Original Article

Understanding beliefs about inhaled medication in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies

Catarina Novais¹, Ana Margarida Cruz^1,2, Ana Margarida Pereira^3,4,5, Rute Almeida⁶, Rita Amaral^6,7,8, João Almeida Fonseca^5,6,9, Cristina Jácome cristinajacome.ft@gmail.com⁶

doi: 10.23822/EurAnnACI.1764-1489.344

Download PDF

Long-term real-world effectiveness of Mepolizumab in EGPA: support for a step-up dosing strategy

Show more: Authors information and Publication history

Authors Information

History

KEY WORDS

Table of Content: Online First

Letter to the Editor

Severe CSU with low total IgE levels: is the response to omalizumab always delayed or absent?

Letter to the Editor

Selective Immunoglobulin M Deficiency: an underestimated immunodeficiency

Letter to the Editor

Challenges in egg allergy: a retrospective look at the utility of cut-off values

Original Article

Quantity increase and functional affinity/avidity decrease of anti-FcεRI and anti-IgE autoantibodies in chronic spontaneous urticaria

Original Article

Understanding beliefs about inhaled medication in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies

Contact